New Oral Agent for Treatment of Anemia in Patient with Chronic Kidney Disease: Prolyl Hydroxylase Inhibitor
KiRyang Na
Korean J Med. 2019;94(1):11-16.   Published online 2019 Feb 1     DOI: https://doi.org/10.3904/kjm.2019.94.1.11
Citations to this article as recorded by Crossref logo
Oxidative Stress Induced by Lipotoxicity and Renal Hypoxia in Diabetic Kidney Disease and Possible Therapeutic Interventions: Targeting the Lipid Metabolism and Hypoxia
Seung Yun Chae, Yaeni Kim, Cheol Whee Park
Antioxidants.2023; 12(12): 2083.     CrossRef